Kodiak Sciences Inc
Kodiak Sciences Inc logo
KOD

Kodiak Sciences Inc (KOD)

$7.751.44%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$7.56
Day's Range
$7.87
$4.9
52-Week Range
$131.97
1 month return1.15%
3 month return2.79%
1 year return91.87%
5 year return23.72%

Company Information

Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new science to the design and manufacture of next generation retinal medicines to prevent and treat the leading causes of blindness globally. Its ABC Platform™ uses molecular engineering to merge the fields of antibody-based and chemistry-based therapies and is at the core of Kodiak's discovery engine. Kodiak's lead product candidate, KSI-301, is a novel anti-VEGF antibody biopolymer conjugate being developed for the treatment of retinal vascular diseases including age-related macular degeneration, the leading cause of blindness in elderly patients in the developed world, and diabetic eye diseases, the leading cause of blindness in working-age patients in the developed world. Kodiak has leveraged its ABC Platform to build a pipeline of product candidates in various stages of development including KSI-501, its bispecific anti-IL-6/VEGF biopolymer conjugate for the treatment of neovascular retinal diseases with an inflammatory component, and the company is expanding its early research pipeline to include ABC Platform based triplet inhibitors for multifactorial retinal diseases such as dry AMD and glaucoma. Kodiak is based in Palo Alto, CA.
OrganizationKodiak Sciences Inc
CEO
IndustryHealth Technology

Analyst Recommendation

based on 13 analysts ratings

Buy
61%
Buy
30%
Hold
7%
Sell

Based on 13 Wall street analysts offering stock ratings for Kodiak Sciences Inc(by analysts ranked 0 to 5 stars)

Recommendation Trend

Based on 13 analyst

Current1M Ago3M Ago
Buy
8
8
8
Hold
4
5
5
Sell
1
1
1
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
303.3M
Book Value
12.89
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-5.15
Wall Street Target Price
19.5

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
0.0
Price/Book (mrq)
0.5
Enterprise Value
-321210580
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
1.24

Technicals

Beta
1.91
50 Day MA
12.29
200 Day MA
71.08

Institutional Holdings

Baker Bros Advisors LP

30.66%

BlackRock Inc

5.49%

Vanguard Group Inc

4.54%

Wellington Management Company LLP

2.8%

Millennium Management LLC

2.03%

Two Sigma Investments LLC

1.9%

Discover more

Frequently Asked Questions

What is Kodiak Sciences Inc share price today?

Can Indians buy Kodiak Sciences Inc shares?

How can I buy Kodiak Sciences Inc shares from India?

Can Fractional shares of Kodiak Sciences Inc be purchased?

What are the documents required to start investing in Kodiak Sciences Inc stocks?

What are today’s High and Low prices of Kodiak Sciences Inc?

What are today’s traded volumes of Kodiak Sciences Inc?

What is today’s market capitalisation of Kodiak Sciences Inc?

What is the 52 Week High and Low Range of Kodiak Sciences Inc?

How much percentage Kodiak Sciences Inc is down from its 52 Week High?

How much percentage Kodiak Sciences Inc is up from its 52 Week low?

What are the historical returns of Kodiak Sciences Inc?

Who is the Chief Executive Officer (CEO) of Kodiak Sciences Inc?